亨廷顿病中轻度认知障碍:挑战和前景
1Institute of Clinical Neurobiology, Alberichgasse 5/13, 1150, Vienna, Austria. kurt.jellinger@univie.ac.at.
Journal of neural transmission (Vienna, Austria : 1996)
|January 24, 2024
概括
亨廷顿病 (HD) 早期认知衰退与大脑网络退化和突触功能障碍有关. 了解这些早期变化对于开发这种神经退行性疾病的有效管理策略至关重要.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 亨廷顿病 (HD) 主要被称为运动障碍,但认知和行为变化是早期和突出的症状.
- 大约40%的症状前阶段的个体表现出轻度认知障碍,往往进展为痴呆症.
- 导致HD认知衰退的确切病原机制尚不清楚.
研究的目的:
- 为了研究亨廷顿病的认知变化的病理生理学.
- 为了获得有关HD早期神经退行性事件的见解.
- 为了确定潜在的生物标志物用于早期检测认知障碍.
主要方法:
- 多模式神经成像用于评估关键大脑区域和网络的灰色和白质变性.
- 用转基因动物模型进行研究,以检查分子变化,突触功能障碍和神经变运输.
- 分析突变狩猎蛋白 (mHTT) 和tau之间的潜在相互作用.
主要成果:
- 多模式成像揭示了在前额前和皮质基底脉回路中广泛的灰色和白质变性.
- 动物模型显示了早期的突触功能障碍,神经营养运输受损,以及导致神经元死亡的分子变化.
- 在皮质,条形体和海马体的突触性损伤与认知和神经精神症状有关.
结论:
- 在HD的认知障碍与影响关键大脑电路的广泛的神经退行过程有关.
- 早期的突触功能障碍和分子变化在HD病变发生过程中起着重要作用.
- 需要进一步的研究,包括神经成像和神经病理学,以开发用于早期检测和干预HD的生物标志物.
相关概念视频
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Cognitive Development During Adulthood
111
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
111
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
Intellectual Disability
54
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
54


